Aratana Therapeutics will make another go at an IPO this week, joining five other companies slated to go public. More
-
Sponsored By:
-
Sponsored By:
-
Sponsored By:
CELG
Recent Articles
Trade of the Day: Celgene (CELG)
This biotech stock has recently been upgraded, and just announced a $3 billion share buyback program. More
Bulls vs. Bears: Can Biogen Keep Booming?
Biogen has been soaring on news of its recent drug approval, but the question remains when it can keep it up. Here are the bullish and bearish arguments. More
10 Best S&P 500 Stocks of Q1
Here’s a look at the 10 best performers in the S&P 500, as well as some thoughts about why they have rallied and what’s in store for them for the rest of the year. More
Pounce on This Biotech Favorite If it Falls Back Into Buying Range
Celgene Corp. (NASDAQ:CELG) broke from a rectangle consolidation, forming a steep bull channel. More
Get This Blazing Hot Biotech for a Reasonable Price
A consolidation in Celgene Corp. is giving traders the perfect opportunity to buy at a bargain. More
3 Healthcare Stocks Ready for a Breather
It's the hottest sector in the S&P 500 so far this year, and that means some big-name pullbacks are likely. Here are three likely candidates. More
